Geographic Market Expansion to Boost Spinraza Sales in 2017
In 3Q17, Biogen (BIIB) and Ionis Pharmaceuticals' (IONS) Spinraza reported sales worth $73 million from international markets.
In 3Q17, Biogen (BIIB) and Ionis Pharmaceuticals' (IONS) Spinraza reported sales worth $73 million from international markets.